Patient A | Patient B | Patient C | Patient D | |
---|---|---|---|---|
Patient characteristics | ||||
Age | 68 years | 69 years | 71 years | 54 years |
Sex | Male | Male | Female | Male |
Hypertension | Yes | Yes | Yes | Yes |
Diabetes mellitus | No | Yes | No | No |
Lesion characteristic | ||||
Long/diffuse lesion (> 20 mm) | Yes | Yes | Yes | Yes |
% Stenosis | 100% | 90–95% | 80% | 99% |
Artery involved | LAD | LAD | RCA | LAD |
Initial angioplasty details | ||||
Stent size deployed | 2.75 × 28 mm | 2.75 × 33 mm | 2.5 × 38 mm | 3 × 28 mm |
Stent type | Xience V | Xience Prime LL | Xience Prime LL | Xience V |
Metal alloy in stent | L605 cobalt chromium | L605 cobalt chromium | L605 cobalt chromium | L605 cobalt chromium |
Drug polymer | Acrylate primer and a fluorinated copolymer | Acrylate primer and a fluorinated copolymer | Acrylate primer and a fluorinated copolymer | Acrylate primer and a fluorinated copolymer |
Drug eluting | Everolimus | Everolimus | Everolimus | Everolimus |
Post dilatation | 3 mm at 15 atm | 3 mm at 13 atm | 2.75 mm at 16 atm | 3.5 mm at 15 atm |
Dual anti-platelet drugs | Ticagrelor + ecospirin | Clopidogrel + ecospirin | Clopidogrel + ecospirin | Ticagrelor + ecospirin |
Patient re admission presentation | ||||
Fever | Nil | Nil | Nil | Nil |
Unstable angina | Yes | Yes | Yes | Yes |
Days after initial angioplasty | 4 months | 3.5 months | 2.5 months | 7 months |
TLC during re-admission | 6600/µL | 7900/µL | 9700/µL | 8200/µL |
Eosinophil count | 600/µL | 800/µL | 1500/µL | 800/µL |
Aneurysm details | One large saccular aneurysm | Three large saccular aneurysms | Two–three small fusiform aneurysms | Two large saccular aneurysms |
Arterial segment involved | Proximal LAD | Proximal LAD | Distal RCA | Left main and proximal LAD |
Second admission treatment | ||||
Angioplasty | Covered stent (3.5 × 26 mm) | Covered stent (3.5 × 19 mm) | Drug eluting stent (2.75 × 23 mm) | Operative repair and grafting |
Outcome | Expired | Expired | Alive | Alive |